1st Quarter - Report

ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION

Firm
Client
Income
—
Expenses
$308,850
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part B and D Telemedicine Medicaid CHIP CHIP Re-authorization S.776 Medication Therapy Management Empowerment Act of 2015 HR 2624/S1488 Part D Beneficiary Appeals Fairness Act FY 17 appropriations for HHS,CDC,NIH,DOD,FOA,VA H.R. 2029 FY16 omnibus Budget Control Act

LobbyistCovered position, as disclosed
ANNA HYDE Director, Health Policy and Federal Affairs
SANDIE J. PREISS Vice President, Advocacy and Access

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2029 (114th), S. 776 (114th), H.R. 2624 (114th)

Health Issues HCR

HR 1600 Patients' Access to Treatments Act HR 6 21st Century Cures/Innovation for Healthier Americans HR 1859 Physician Workforce/Pediatric Subspecialty Loan Repayment Biosimilars guidance, oversight FDA

LobbyistCovered position, as disclosed
ANNA HYDE Director, Health Policy and Federal Affairs
SANDIE J. PREISS Vice President, Advocacy and Access

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1859 (114th), H.R. 6 (114th), H.R. 1600 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.